AMAG Pharmaceuticals Responds to Recent Complete Response Letter From the FDA for the Single-Dose, Preservative-Free Vial of Makena(R)

By: via Benzinga
AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) today announced that it responded to the U.S. Food and Drug Administration (FDA), providing ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.